Literature DB >> 22110282

Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption.

Francesco Manguso1, Elisabetta Riccio, Germana de Nucci, Maria Luisa Aiezza, Gerardino Amato, Linda Degl'Innocenti, Maria Maddalena Piccirillo, Gianfranco De Dominicis, Tara Santoro, Elena Trimarco, Antonio Balzano.   

Abstract

AIM: To establish the prevalence of Helicobacter pylori (H. pylori) infection in patients with a bleeding peptic ulcer after consumption of non-steroidal antiinflammatory drugs (NSAIDs).
METHODS: A very early upper endoscopy was performed to find the source of upper gastrointestinal bleeding and to take biopsy specimens for analysis of H. pylori infection by the rapid urease (CLO) test, histological examination, and bacterial culture. IgG anti-CagA were also sought. The gold standard for identifying H. pylori infection was positive culture of biopsy specimens or contemporary positivity of the CLO test and the presence of H. pylori on tissue sections.
RESULTS: Eighty patients, 61 males (76.3%), mean age 61.2 ± 15.9 years, were consecutively enrolled. Forty-seven (58.8%) patients occasionally consumed NSAIDs, while 33 (41.3%) were on chronic treatment with low-dose aspirin (LD ASA). Forty-four (55.0%) patients were considered infected by H. pylori. The infection rate was not different between patients who occasionally or chronically consumed NSAIDs. The culture of biopsy specimens had a sensitivity of 86.4% and a specificity of 100%; corresponding figures for histological analysis were 65.9% and 77.8%, for the CLO test were 68.2% and 75%, for the combined use of histology and the CLO test were 56.8% and 100%, and for IgG anti-CagA were 90% and 98%. The highest accuracy (92.5%) was obtained with the culture of biopsy specimens.
CONCLUSION: Patients with a bleeding peptic ulcer after NSAID/LD ASA consumption frequently have H. pylori infection. Biopsy specimen culture after an early upper gastrointestinal tract endoscopy seems the most efficient test to detect this infection.

Entities:  

Keywords:  Endoscopy; Helicobacter pylori; Helicobacter pylori infection; Low-dose aspirin; Non-steroidal antiinflammatory drugs; Peptic ulcer hemorrhage

Mesh:

Substances:

Year:  2011        PMID: 22110282      PMCID: PMC3218142          DOI: 10.3748/wjg.v17.i40.4509

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

Review 1.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  The role of anesthesia in surgical mortality.

Authors:  R D DRIPPS; A LAMONT; J E ECKENHOFF
Journal:  JAMA       Date:  1961-10-21       Impact factor: 56.272

3.  Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

4.  Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?

Authors:  S Jyotheeswaran; A N Shah; H O Jin; G D Potter; F V Ona; W Y Chey
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Risk assessment after acute upper gastrointestinal haemorrhage.

Authors:  T A Rockall; R F Logan; H B Devlin; T C Northfield
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

8.  Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers.

Authors:  T C Tu; C L Lee; C H Wu; T K Chen; C C Chan; S H Huang; S C Lee MS
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

9.  [Prospective study on the influence of gastroduodenal ulcer hemorrhage on the diagnostic methods in Helicobacter pylori infection].

Authors:  M Romero Gómez; J Vargas; D Utrilla; M C Rufo; M A Otero; M Chavez; J L Larraona; L Castilla; P Guerrero; L Grande; M Castro Fernández
Journal:  Gastroenterol Hepatol       Date:  1998 Jun-Jul       Impact factor: 2.102

10.  What is the best method to diagnose Helicobacter infection in bleeding peptic ulcers?: a prospective trial.

Authors:  I K Chung; S J Hong; E J Kim; J Y Cho; H S Kim; S H Park; M H Lee; S J Kim; C S Shim
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

View more
  4 in total

Review 1.  Coming to terms with nonsteroidal anti-inflammatory drug gastropathy.

Authors:  Sanford H Roth
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

2.  Upper Gastrointestinal Bleeding in Children: The Role of Helicobacter pylori Infection and Non-steroidal Anti-inflammatory Drug Use.

Authors:  M Usta; N Urganci
Journal:  West Indian Med J       Date:  2015-01-29       Impact factor: 0.171

Review 3.  Accuracy of the Helicobacter pylori diagnostic tests in patients with peptic ulcer bleeding: a systematic review and network meta-analysis.

Authors:  Nóra Vörhendi; Alexandra Soós; Marie Anne Engh; Benedek Tinusz; Zsolt Szakács; Dániel Pécsi; Alexandra Mikó; Patrícia Sarlós; Péter Hegyi; Bálint Eröss
Journal:  Therap Adv Gastroenterol       Date:  2020-12-16       Impact factor: 4.409

Review 4.  Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections.

Authors:  Ting-Chun Huang; Chia-Long Lee
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.